The World Orphan Drug Congress is the largest and most established orphan drugs & rare disease meeting of its kind across the globe. Now in its 16th edition; it boasts a prestigious advisory board that curates a topical agenda annually. The event gathers experts from across the value chain where attendees can explore solutions for challenges related to OMP legislation; EUHTA; and various scientific and commercial issues. Recognized as the largest multi-stakeholder rare disease meeting; it features an outstanding speaker lineup and integrates the patient voice through strategic partnerships with major rare disease organizations.